Technical Analysis for CBIO - Catalyst Inc.

Grade Last Price % Change Price Change
grade D 10.33 -0.29% -0.03
CBIO closed down 0.29 percent on Friday, August 17, 2018, on 24 percent of normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical CBIO trend table...

Date Alert Name Type % Chg
Aug 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Aug 17 Bollinger Band Squeeze Range Contraction 0.00%
Aug 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.29%
Aug 16 Bollinger Band Squeeze Range Contraction -0.29%
Aug 16 Multiple of Ten Bullish Other -0.29%
Aug 16 Inside Day Range Contraction -0.29%
Aug 15 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.97%
Aug 15 Bollinger Band Squeeze Range Contraction 1.97%
Aug 15 Doji - Bearish? Reversal 1.97%
Aug 15 Doji - Bullish? Reversal 1.97%

Older signals for CBIO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Catalyst Biosciences, Inc., a biopharmaceutical company, focuses on discovering and developing novel biopharmaceutical products based on engineered human proteases. The company designs its proteases to promote hemostasis and to prevent inflammation. Its pipeline of protease therapeutics include CB 813d/PF-05280602, an engineered Factor VIIa drug candidate that completed a Phase 1 clinical trial evaluating safety and tolerability, as well as pharmacokinetics, pharmacodynamics, and coagulation activity. The company's pre-clinical development stage drugs comprise CB 2679d/ISU 304, a next-generation Factor IX drug for the treatment of hemophilia B inhibitor patients; and an engineered Factor Xa for hemophilia and the control of bleeding in non-hemophilia patients. It also develops factor C3 for the prevention of renal delayed graft function and the treatment of dry age-related macular degeneration. Catalyst Biosciences, Inc. is headquartered in South San Francisco, California.
Is CBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 37.0
52 Week Low 3.11
Average Volume 839,505
200-Day Moving Average 18.4825
50-Day Moving Average 12.4376
20-Day Moving Average 10.152
10-Day Moving Average 10.232
Average True Range 0.6765
ADX 14.42
+DI 16.5314
-DI 17.7401
Chandelier Exit (Long, 3 ATRs ) 9.3205
Chandelier Exit (Short, 3 ATRs ) 11.3295
Upper Bollinger Band 10.7287
Lower Bollinger Band 9.5753
Percent B (%b) 0.65
BandWidth 11.361308
MACD Line -0.6522
MACD Signal Line -0.9081
MACD Histogram 0.2559
Fundamentals Value
Market Cap 44.51 Million
Num Shares 4.31 Million
EPS -14.07
Price-to-Earnings (P/E) Ratio -0.73
Price-to-Sales 35.66
Price-to-Book 0.66
PEG Ratio 0.03
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.84
Resistance 3 (R3) 10.84 10.68 10.76
Resistance 2 (R2) 10.68 10.55 10.68 10.73
Resistance 1 (R1) 10.50 10.47 10.42 10.50 10.70
Pivot Point 10.34 10.34 10.30 10.34 10.34
Support 1 (S1) 10.16 10.21 10.08 10.16 9.96
Support 2 (S2) 10.00 10.13 10.00 9.93
Support 3 (S3) 9.82 10.00 9.91
Support 4 (S4) 9.82